Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 5,000 shares at $95.37 ($477K) on 2023-07-18, disclosed to the SEC on 2023-07-19.
Open-market sale of $477k TMDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |